NOS3 and necrotizing enterocolitis: Our suggestion corresponds with the results of Drucker et al. [38], who showed that GYY-4137 improved mesenteric perfusion and intestinal injury in experimental necrotizing enterocolitis, whereas these benefits were mediated through eNOS-dependent promotion of mesenteric vessels vasodilation.